EXPERIMENTAL AND MOLECULAR MEDICINE
Scope & Guideline
Unraveling the complexities of health and disease.
Introduction
Aims and Scopes
- Molecular Mechanisms of Disease:
Focuses on the molecular pathways involved in various diseases, including cancer, metabolic disorders, and neurodegenerative diseases, providing insights into potential therapeutic targets. - Experimental Models and Techniques:
Utilizes diverse experimental models, including organoid systems, animal models, and advanced imaging techniques, to investigate disease mechanisms and test therapeutic interventions. - Translational Research:
Emphasizes the translation of laboratory findings into clinical applications, bridging the gap between basic science and clinical practice, particularly in oncology and regenerative medicine. - Immunology and Inflammation:
Explores the roles of immune responses and inflammation in disease progression and therapy, with a focus on therapeutic strategies that modulate immune pathways. - Genomics and Epigenetics:
Investigates the impact of genomic and epigenetic alterations on disease development and progression, employing cutting-edge sequencing technologies to elucidate complex biological processes. - Microbiome and Disease Interactions:
Examines the interactions between the microbiome and host physiology, particularly how these interactions influence disease states and therapeutic outcomes. - Advanced Therapeutics and Drug Development:
Covers innovative approaches in drug discovery, including the development of novel therapeutic agents, biomarker identification, and personalized medicine strategies.
Trending and Emerging
- Organoid Technology and Applications:
The use of organoids as models for disease research is rapidly expanding, allowing for more accurate studies of human physiology and disease mechanisms, as well as drug testing. - Targeted Cancer Therapies:
There is a growing focus on developing targeted therapies that exploit specific molecular pathways in cancer, reflecting advances in precision medicine. - RNA Biology and Therapeutics:
Research on the roles of non-coding RNAs, including microRNAs and long non-coding RNAs, is trending, with implications for cancer therapy and gene regulation. - Immunotherapy and Immune Modulation:
The exploration of novel immunotherapeutic strategies, including the manipulation of immune pathways and the development of immune checkpoint inhibitors, is gaining momentum. - Metabolic Reprogramming in Disease:
Research into how metabolic changes affect disease progression, particularly in cancer and metabolic disorders, is emerging as a critical area of study. - Microbiome Research and Health:
The investigation of the microbiome's role in health and disease is increasingly prominent, with implications for therapeutic interventions and understanding disease mechanisms. - Epigenetics and Disease:
The study of epigenetic modifications and their impact on gene expression and disease development is on the rise, highlighting the complexity of genetic regulation.
Declining or Waning
- Traditional Pharmacology:
Research focused on classical pharmacological approaches is less prevalent, as more emphasis is placed on targeted therapies and personalized medicine. - Basic Biochemistry:
While foundational biochemistry remains important, there is a noticeable shift towards more complex systems biology and molecular mechanisms, leading to a decline in studies centered solely on basic biochemical processes. - In vitro Cell Culture Studies:
The reliance on conventional in vitro studies has decreased, with a growing preference for more sophisticated models, such as organoids and 3D cultures, which better mimic in vivo conditions. - Animal Models of Disease:
The use of traditional animal models is declining in favor of more innovative and relevant models that can better replicate human disease mechanisms and responses to treatments. - Single Biomarker Studies:
Research focusing on single biomarkers is becoming less common as the field shifts towards integrative approaches that consider multiple factors and interactions within biological systems.
Similar Journals
CURRENT MOLECULAR MEDICINE
Transforming Insights into Impactful Healthcare SolutionsCURRENT MOLECULAR MEDICINE is a pivotal journal fostering advancements in the interdisciplinary fields of molecular medicine, biochemistry, and genetics. Published by Bentham Science Publishers, this esteemed journal has been disseminating vital research findings since its inception in 2001 and is continuously dedicated to exploring the molecular basis of health and disease. With a focus on translational research, CURRENT MOLECULAR MEDICINE provides an invaluable platform for researchers, healthcare professionals, and students, making significant contributions to the understanding of molecular mechanisms and therapeutic strategies. With an ISSN of 1566-5240 and an E-ISSN of 1875-5666, the journal holds a commendable position within the scientific community, being ranked Q3 in Biochemistry and Molecular Biology and Q2 in Medicine (miscellaneous) as of 2023. This journal does not currently operate on an open access model but remains accessible through various institutional subscriptions. The multidisciplinary scope covering molecular biology to medicinal applications positions CURRENT MOLECULAR MEDICINE as an essential resource for those striving to meet the challenges of modern healthcare and biomedical research.
JOURNAL OF MOLECULAR MEDICINE-JMM
Unveiling the Molecular Mysteries of Health and Disease.JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.
Cell Reports Medicine
Empowering researchers with accessible, high-impact findings.Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.
Genes & Diseases
Exploring the molecular pathways of health and illness.Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
Exploring Innovations in Experimental Biology and MedicineBULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE is a prestigious journal published by SPRINGER, dedicated to advancing knowledge in the fields of biochemistry, genetics, molecular biology, and medicine. Established in 1956 and continuing to be relevant through to 2024, this journal provides a vital platform for researchers to publish original findings and significant reviews that contribute to these essential disciplines. With an ISSN of 0007-4888 and an E-ISSN of 1573-8221, it enjoys a respectable standing in the academic community, currently positioned in the Q3 quartile of both Biochemistry, Genetics and Molecular Biology, and Medicine categories for 2023. Despite its traditional subscription model, the journal reaches a wide audience of professionals, students, and researchers, who benefit from timely access to impactful research and experimental studies. By fostering a rich dialogue in experimental biology and medicine, this journal plays an important role in shaping ongoing research and understanding of complex biological systems.
Frontiers in Bioscience-Landmark
Pioneering Insights in Bioscience ResearchFrontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Advancing Insights into Molecular MechanismsBIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.
MOLECULES AND CELLS
Elevating Research, Shaping the Future of BiologyMOLECULES AND CELLS is a distinguished peer-reviewed journal published by the Korean Society for Molecular and Cellular Biology, dedicated to advancing the fields of Cell Biology, Molecular Biology, and Medicine. With a solid citation record and a robust reputation in its respective categories, the journal has achieved a ranking of Q2 in Cell Biology and Q1 in Miscellaneous Medicine as of 2023, demonstrating its impact and relevance to ongoing research in these vital disciplines. Although currently not open access, MOLECULES AND CELLS strives to provide a platform for innovative studies from diverse areas within molecular and cellular research, fostering collaboration among scientists worldwide. Established in 1996 and continuing to publish leading-edge research until 2024, this journal is essential for researchers, professionals, and students seeking to engage with the latest developments and insights in the life sciences.
FASEB BioAdvances
Unlocking the Secrets of Life SciencesFASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.
Frontiers in Molecular Biosciences
Advancing Knowledge in Molecular BiosciencesFrontiers in Molecular Biosciences is an esteemed open-access journal published by FRONTIERS MEDIA SA, based in Switzerland. Since its inception in 2014, the journal has made significant strides in the fields of biochemistry, genetics, and molecular biology, cementing its reputation with a solid position in the Q1 quartile for both Biochemistry and Genetics and Molecular Biology (miscellaneous) categories as of 2023. With a remarkable Scopus rank of #14/103 in the combined categories, it offers an essential platform for the dissemination of high-quality research that shapes the understanding of molecular processes and their implications in health and disease. The journal’s commitment to open access facilitates the broadest possible reach for groundbreaking discoveries, serving as a vital resource for researchers, professionals, and students alike. Located at AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, this journal continues to foster innovative discussions and advancements in molecular biosciences, paving the way for new insights and collaborations in the scientific community.